key: cord-0773013-w2s1bcp6 authors: Hemilä, Harri; Chalker, Elizabeth title: Vitamin C as a Possible Therapy for COVID-19 date: 2020-05-15 journal: Infect Chemother DOI: 10.3947/ic.2020.52.2.222 sha: 686e2e2ce2dbcb624dcbdbc396f47bc8ac95d53c doc_id: 773013 cord_uid: w2s1bcp6 nan . We would like to propose that vitamin C should also be included as a possible treatment as it has numerous effects on the immune system [2, 3] . In a meta-analysis of 29 controlled trials with 11,306 participants, we showed that regular vitamin C intake of around 1 g/day did not prevent upper respiratory tract infections (URTIs) [4] . However, the same trials found that vitamin C shortened and alleviated URTIs that occurred during the period of vitamin C administration. In adults the duration of infections was reduced by 8% and in children by 14% [4] . Given the low frequency and usually mild symptoms of URTIs, and the relatively small benefit, prophylactic daily vitamin C dosing does not seem worthwhile under normal circumstances. However, noting that many URTIs are caused by endemic coronaviruses, there is no reason or evidence to assume that vitamin C would be completely ineffective against COVID-19. Given that COVID-19 is often much more severe than ordinary URTIs, the above estimates might justify a regular increased daily intake of vitamin C while the prevalence of COVID-19 is high. Furthermore, one of the major causes for concern with COVID-19 is the relatively high proportion of cases requiring intensive care unit (ICU) treatment. A meta-analysis of 12 trials with 1,766 patients in ICU found that vitamin C shortened ICU stay by 8% [5] . Another metaanalysis of eight trials found that vitamin C shortened the duration of mechanical ventilation in patients who required the longest ventilation [6] . There is evidence that vitamin C levels decline dramatically in critically ill patients [5, 7] . Although 0.1 g/day of vitamin C can maintain a normal plasma level in a healthy person [8] , much higher doses (1 -4 g/day) are needed to increase plasma vitamin C levels of critically ill patients to within the normal range [5, 9] . Vitamin C is a safe and inexpensive essential nutrient and therefore investigation of its possible effects on COVID-19 should be encouraged along with the several other potential treatments [1] . Interim guidelines on antiviral therapy for COVID-19 Vitamin C promotes maturation of T-cells Vitamin C and immune function nutrients Vitamin C for preventing and treating the common cold Vitamin C can shorten the length of stay in the ICU: a meta-analysis Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance Oudemans-van Straaten HM. Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four iv regimens